Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Case reports of latent HBV hepatitis in patients after neurosurgical treatment for hypothalamic and pituitary tumors

Fig. 2

Clinical course of case 2, 47-year-old female, corticotroph cell adenoma. Entecavir was administered 22 days before transsphenoidal surgery and discontinued 2 years after the surgery. HBV-DNA level was temporary increased after the surgery, and immediately decreased to lower detection sensitivity. Steroid coverage was discontinued 3 days after the surgery

Back to article page
\